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In placental mammals, viviparity—the production
of living young within the mother’s body—evolved
under the auspices of the immune system. Elements
of immunity were incorporated, giving pregnancy a
mildly inflammatory character. Formation of the
placenta, the organ that feeds the fetus, involves a
cooperation between maternal natural killer (NK)
cells and fetal trophoblast cells that remodels the
blood supply. Recent research reveals that this pro-
cess and human reproductive success are influenced
by polymorphic HLA-C ligands and their killer cell
immunoglobulin-like receptors (KIR).
 
Placental Reproduction Incorporates Innate Immune Mecha-
nisms.
 
The first mammals were not viviparous but oviparous.
They laid eggs, as is still done by the duck-billed platypus
and both the long- and short-beaked echidnas (1). At the
time of ancestral mammals, 
 
 
 
220 million years ago, the
fundamentals of immunity as we know it were already in
place (2). It was within this context that mammalian vivi-
parity and placental reproduction began to evolve 
 
 
 
100
million years ago (3, 4) and use aspects of the immune sys-
tem. Resisting infection and reproducing its kind are abso-
lute essentials if a new species is to compete and survive for
any length of time. The competition is such (all species lose
eventually) that successful immune and reproductive sys-
tems maintain their edge by adapting to changing circum-
stance. Consequently, these two systems vary widely among
extant mammals (5, 6, 7). In particular, human reproduc-
tion can seem bizarre and inexplicably divergent from that
of other species (8).
In its broadest sense, the immune system’s job is to de-
molish, disinfect, and rebuild damaged tissues (9). Repro-
duction involves similar processes, which are driven by
hormones rather than microbial trespass. In women of
child-bearing age who are not pregnant, the outermost part
of the epithelial lining of the uterus (the endometrium) is
pulled apart and refashioned on a regular basis—the 28-d
menstrual cycle (10). During the 9-d proliferative phase
preceeding ovulation, the endometrium becomes built up,
richly vascularized, and infiltrated with small, agranular NK
cells (11, 12). Ovulation marks the beginning of the 14-d
secretory phase in which the NK cells proliferate and dif-
ferentiate. In this phase, an embryo can implant, but in its
absence NK cells die off and the outer endometrium sheds
during the 5-d period of bleeding known as menstruation.
Upon implantation of an embryo, the menstrual cycle is
broken and pregnancy commences. The implanted em-
bryo, the blastocyst, comprises an inner cell mass, which
develops into the fetus, and an outer trophoblast layer that
forms the placenta. By tapping into the maternal circulation,
the placenta serves the fetus with food procured from the
mother’s blood. Obtaining adequate blood supply necessi-
tates some remodeling of blood vessels in the outer en-
dometrium, which in the process becomes a much changed
tissue called the decidua. The work involves an expanded
and activated population of maternal NK cells in the decidua
and extravillous trophoblast cells. The latter are directed to
move into the decidua, where they strip off the muscular
wall of the spiral arteries and supplant the endothelial cells
that line these vessels (Fig. 1) (10).
Human spiral arteries are remodeled to a much greater
depth than those of other species—a process that is only com-
pleted by weeks 16–20 of pregnancy (13). The once muscular
vessels are converted into large flaccid conduits to meet the es-
calating demands of the human fetus, particularly those of its
exceptionally large brain (8, 14). Although the decidual NK
cell population dwindles in the second half of pregnancy—and
by birth is gone—during this period the maternal–fetal inter-
action creates a state of mild systemic inflammation, as typified
by activated vascular endothelium, leukocytes, and plasma
proteins (15). Metabolic changes occur, including insulin resis-
tance, that could serve to divert nutrients away from the
mother and toward the growing fetus. Thus, cellular and mo-
lecular components of innate immunity are seen to be active
throughout the duration of pregnancy: NK cells in the first
half and inflammation in the second half.
 
Uterine NK Cells Differ from Those in the Blood.
 
NK
cells constitute 50–90% of the leukocytes in the decidua, a
tissue in which B and T cells are rare. Two types of periph-
eral blood NK cells are distinguished: those with low
CD56 expression specialize in cytolysis, whereas those with
high CD56 favor cytokine secretion (16). Uterine NK cells
express the highest amounts of CD56 and are also skewed
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toward cytokine secretion (17). Analysis of the transcrip-
tion of 10,000 genes revealed 278 whose expression dif-
fered by more than threefold in uterine NK cells compared
with blood NK cells (18). Most of these genes were up-
regulated in the uterine NK cells. It is still unknown
whether these differences arise from differentiation that oc-
curs within the decidua or from expansion there of rare
precursors from the peripheral blood with atypical pheno-
type. Either way the extent of the differences points to
uterine NK cells having functions specific to pregnancy.
Evidence from several quarters supports the view that
decidual NK cells cooperate with extravillous trophoblasts
to remodel the spiral arteries. Of the various forms of tro-
phoblast, only the extravillous trophoblasts express MHC
class I molecules, and those they express—HLA-C, E and
G—are all good ligands for NK cell receptors (19). HLA-G
is expressed only by extravillous trophoblasts and medul-
lary epithelial cells of the thymus (20), whereas HLA-C
and HLA-E have ubiquitous distribution. HLA-G is the
LILRB1 ligand (21), HLA-E is the ligand for CD94–
NKG2A/C (22), and HLA-C ligands engage several mem-
bers of the KIR family (23). These ligand–receptor pairs
provide candidates for controlling the interaction of decid-
ual NK cells with extravillous trophoblast cells, liaisons
which are clearly visible under the microscope (Fig. 1).
 
Combinations of Maternal KIR and Fetal HLA-C Affect
Preeclampsia.
 
Preeclampsia is a disorder specifically of hu-
man reproduction that becomes manifest during the second
half of 5–10% of pregnancies (24). It can be caused by in-
complete remodeling of the spiral arteries, which leads to
high maternal blood pressure and elevated concentration of
urinary protein. Although originating in the placenta, the
effects of preclampsia become systemic: perturbation of
maternal circulation and poor fetal growth (15). In the ab-
sence of care or intervention, preeclampsia can deteriorate
into eclampsia, which threatens vital maternal organs and
can lead to death for both mother and child. If only one of
them dies, it is usually the mother. Worldwide, most preg-
nancy-associated mortality is due to preeclampsia and
eclampsia. Convulsions typify eclampsia, hence the name
which derives from eklampsis, the Greek word for a sud-
den flash or development (25). The only known cure for
preeclampsia is to deliver the fetus, the physician’s chal-
lenge being to balance the needs of both mother and child
in deciding when to intervene with either drug-induced la-
bor or a cesaerian section (24).
Hearsay and clinical observation pointed to the possibility
that polymorphisms in both maternal and paternal genes
contribute to preeclampsia. Maternally, preeclampsia runs in
families, and some men seem prone to fathering preeclamp-
tic pregnancy (10). In this issue, Hiby et al. implicate HLA-C
on fetal trophoblast cells and KIR on uterine NK cells as
factors affecting preeclampsia (26). These particular tropho-
blast ligands and NK cell receptors were selected for study
because they were known to have extensive polymorphism
of immunological importance. Hiby et al. compared a panel
Figure 1. In pregnancy, the spiral arteries are remodeled by extravillous trophoblast cells and NK cells. The left panel shows the nonpregnant en-
dometrium in the secretory phase of the menstrual cycle just before menstruation. The right panel shows the endometrium in the second half of normal
pregnancy when the spiral arteries are remodeled to a depth that penetrates the myometrium. The middle panel shows the situation in preeclampsia
where the extent and depth of remodeling is less than in normal pregnancy. These vascular changes are effected by extravillous trophoblast cells (EVT)
with the help of activated NK cells. In the process, the enlarged vessels become lined with endovascular trophoblast cells (ENVT) (10). 
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of 200 pregnant women with preeclampsia and 201 women
with normal pregnancies. For these women and their babies
 
KIR
 
 and 
 
HLA-C
 
 genotypes were determined. Although
 
HLA-C
 
 and 
 
KIR
 
 are both exceedingly diverse, there is hier-
archy to their variability, which allows the two systems to
be simplified in functionally sensible ways.
The 
 
KIR
 
 locus consists of 7–15 closely packed genes,
which form numerous haplotypes that differ in both gene
content and allele combination. 
 
KIR
 
 haplotypes form two
groups, designated 
 
A
 
 and 
 
B
 
 based on the relative content of
genes encoding inhibitory and activating KIR (27). The
simpler group, 
 
A
 
 haplotypes, contains mainly genes for in-
hibitory KIR, whereas the more complicated group, 
 
B
 
haplotypes, has additional genes encoding activating KIR.
Hiby et al. found preeclampsia to be more prevalent in
women who are homozygous for group 
 
A KIR
 
 haplotyes
(
 
AA
 
) than women who are either heterozygous (
 
AB
 
) or
homozygous for group 
 
B
 
 haplotypes (
 
BB
 
) (26). In short, an
absence of activating KIR favors preeclampsia.
HLA-C allotypes form two groups according to KIR
specificity and the residue present at position 80 in the
amino-acid sequence (28). The C1 group allotypes are
ligands for the inhibitory KIR2DL2 and KIR2DL3 and
have asparagine at position 80; the C2 group allotypes are
ligands for the inhibitory KIR2DL1 and the activating
KIR2DS1 and have lysine at position 80. Of the two, C2 is
a stronger ligand than C1 (29). Hiby et al. found that the
increased prevalence of preeclampsia in 
 
AA
 
 
 
KIR
 
 women
was entirely due to pregnancies where the fetus genotype is
either homozygous 
 
C2
 
 or heterozygous 
 
C1C2
 
. Thus, it is
the combination of maternal 
 
AA
 
 
 
KIR
 
 genotype and fetal
 
C2
 
 genotype which most frequently leads to preeclampsia
(Fig. 2) (26).
For the interaction between extravillous trophoblast and
uterine NK cells, the combination of fetal 
 
HLA-C2
 
 and
maternal 
 
AA
 
 
 
KIR
 
 genotype is the one expected to deliver
the strongest inhibitory signals to NK cells. C2 binds more
tightly to its cognate KIR than C1, and maternal NK cells
of 
 
AA
 
 genotype can express the inhibitory C2 receptor
(KIR2DL1) but not the activating KIR that could provide
compensatory activating signals. When comparing disease
status and maternal 
 
KIR
 
 genotype for all the pregnancies
involving a C2 fetus, Hiby et al. found that activating KIR
decrease the likelihood of preeclampsia and that their ef-
fects are cumulative (26). These correlations all point to
overly inhibited uterine NK cells causing trophoblast cells
to prematurely cease the remodeling of maternal blood ves-
sels, thereby increasing the probability for preeclampsia.
This model also ties in nicely with studies of pregnant NK
cell–defective mice, revealing impaired modification of the
spiral arteries that is remedied by administration of inter-
feron 
 
 
 
, a prominent NK cell cytokine (30, 31). Con-
versely, insufficient inhibition of decidual NK cells may fa-
vor spontaneous abortion (32).
The association of 
 
KIR
 
 and 
 
HLA-C
 
 with preeclampsia is
not a simple all-or-nothing phenomenon like the type seen
when a unique gene function is completely missing. Only a
minority of pregnancies with 
 
C2
 
 fetuses and 
 
AA
 
 mothers
lead to preeclampsia, and not all preeclamptic pregnancies
have this genotype combination. Hiby et al. suggest that,
quantitatively, there exists a spectrum of predisposition to
preeclampsia due to different HLA class I–KIR combina-
tions, of which only the most prominent reached statistical
significance in their study (26). This genetic complexity
echoes the complications confronted clinically in defining
and diagnosing preeclampsia, which can be considered not
so much a disease or disorder but “simply the extreme end
of a continuum of characteristics common to all pregnan-
cies” (15).
 
Natural Selection by Preeclampsia.
 
In the absence of suc-
cessful medical intervention, preeclampsia is a significant
cause of mortality for pregnant women and their young.
This is seen in developing countries today (33) and would,
historically, have been universally true. In human popula-
tions, deaths from preeclampsia are predicted to reduce the
frequency of 
 
C2 HLA-C
 
, group 
 
A KIR
 
,
 
 
 
or both factors.
Hiby et al. found evidence for such selection in the 
 
HLA-C
 
and 
 
KIR
 
 frequencies of modern human populations. Over-
all, they observed an inverse correlation between the fre-
Figure 2. Preeclampsia is associated with uterine NK cells of KIR geno-
type AA and the presence of HLA-C2 on the surface of extravillous tro-
phoblast cells. An extravillous trophoblast (EVT) is shown interacting
with a maternal uterine NK cell. EVT are the only trophoblast cells that
express MHC class I. The HLA-C2 molecule is shown interacting with
its cognate inhibitory receptor KIR2DL1. The inhibition due to this
ligand–receptor interaction favors preeclampsia in the absence of com-
pensating activating KIR. The functional KIR genes of a group A haplo-
type are shown in order below the NK cell. The KIR nomenclature give
the number of a receptor’s extracellular domains (2D or 3D) the length of
the cytoplasmic tail (long or short) and a final number distinguishing
receptors with similar structure. Long-tailed KIR inhibit and short-tailed
KIR activate, except KIR2DL4 which does both. HLA-C2 refers to any one
of the HLA-C allotypes that has lysine at position 80. Many other ligand–
receptor pairs that contribute to the cell–cell interaction are not depicted. 
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quencies of 
 
C2
 
 and the 
 
AA KIR
 
 genotype. Populations
with the highest frequency of 
 
AA KIR
 
—Japanese and Ko-
reans—have the lowest 
 
C2
 
 frequencies, whereas popula-
tions with the lowest frequency of 
 
AA KIR
 
—Aboriginal
Australians and Asian Indians—have the highest 
 
C2
 
 fre-
quencies. This striking correlation indicates that selection
for reproductive success has shaped the polymorphisms of
 
HLA class I
 
 and 
 
KIR
 
 and could be solely responsible for
the emergence and maintenance of the balanced polymor-
phisms between the 
 
C1
 
 and 
 
C2
 
 groups of 
 
HLA-C
 
 alleles
and the group 
 
A
 
 and group 
 
B KIR
 
 haplotypes, all of which
are rather new, having originated during the evolution of
the great apes and humans (34, 35). In this scenario, some
mortality from preeclampsia is the price paid for increasing
brain size and the competitive advantages that brings.
 
A Peaceful Paradigm for Reproductive Immunology.
 
The
cells and molecules of the immune system are commonly
depicted as the armies and weaponry with which a mam-
malian host engages in epic struggle with a fiendish micro-
bial empire. In reproductive immunology such martial
metaphor has also been a guiding light, with the twist that
the conflict is between mother and fetus. The fetus is per-
ceived as invading the mother and the mother rebuked for
not rejecting its allogeneic advances. Apart from the obvi-
ous problem with this thesis—that fetal rejection is a trait
unlikely to be passed on—its implication, that the fetus has
an adversarial relationship with the mother’s immune sys-
tem, is inherently unlikely, not least because mammalian
viviparity and placentation began evolving long after the
immune system was put in place. This evolution, which
was very successful, would not have involved sudden con-
frontations of the type experienced by a laboratory mouse
when it is given an MHC-incompatible skin graft. A more
sensible paradigm is now emerging, one in which cells and
molecules of immunity are part and parcel of the reproduc-
tive process and used in a constructive manner. With this
the relationship between uterine NK cells and extravillous
trophoblast cells appears as cooperation, a partnership in
pregnancy, rather than trench warfare between defenders
of the mother country and fetal invaders in search of blood.
 
I thank Laurent Abi-Rached for helpful and stimulating discussion
on questions of evolution.
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